Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers

Molecular Genetics and Metabolism

Volumn 94, Issue 4, 2008, Pages 491-497

  Willis, John H ^a   Isaya, Grazia ^b   Gakh, Oleksandr ^b   Capaldi, Roderick A ^a   Marusich, Michael F ^a  

^a MitoSciences Inc   (United States)

^b Mayo Clinic   (United States)

Author keywords

Diagnostic; Frataxin; Friedreich's ataxia; Lateral flow immunoassay; Mitochondria; Prognostic; Theranostic

Indexed keywords

FRATAXIN; RECOMBINANT FRATAXIN; RECOMBINANT PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; FRIEDREICH ATAXIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WHOLE CELL;

ADOLESCENT; ADULT; AGE OF ONSET; CELLS, CULTURED; CHILD; COHORT STUDIES; FEMALE; FRIEDREICH ATAXIA; HETEROZYGOTE; HUMANS; IMMUNOASSAY; IRON-BINDING PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 46749124616     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.03.019     Document Type: Article

References (42)

1. Harding A.E. Classification of the hereditary ataxias and paraplegias. Lancet 1 (1983) 1151-1155
2. Campuzano V., Montermini L., Molto M.D., Pianese L., Cossee M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Canizares J., Koutnikova H., Bidichandani S.I., Gellera C., Brice A., Trouillas P., De Michele G., Filla A., De Frutos R., Palau F., Patel P.I., Di Donato S., Mandel J.L., Cocozza S., Koenig M., and Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271 (1996) 1423-1427
3. Delatycki M.B., Williamson R., and Forrest S.M. Friedreich ataxia: an overview. J. Med. Genet. 37 (2000) 1-8
4. Pandolfo M. Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations. Methods Mol. Med. 126 (2006) 197-216
5. Patel P.I., and Isaya G. Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency. Am. J. Hum. Genet. 69 (2001) 15-24
6. De Michele G., Filla A., Cavalcanti F., Di Maio L., Pianese L., Castaldo I., Calabrese O., Monticelli A., Varrone S., Campanella G., et al. Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. J. Neurol. Neurosurg. Psychiatry 57 (1994) 977-979
7. Filla A., De Michele G., Cavalcanti F., Pianese L., Monticelli A., Campanella G., and Cocozza S. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 59 (1996) 554-560
8. Bidichandani S.I., Ashizawa T., and Patel P.I. Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am. J. Hum. Genet. 60 (1997) 1251-1256
9. Cossee M., Durr A., Schmitt M., Dahl N., Trouillas P., Allinson P., Kostrzewa M., Nivelon-Chevallier A., Gustavson K.H., Kohlschutter A., Muller U., Mandel J.L., Brice A., Koenig M., Cavalcanti F., Tammaro A., De Michele G., Filla A., Cocozza S., Labuda M., Montermini L., Poirier J., and Pandolfo M. Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann. Neurol. 45 (1999) 200-206
10. Montermini L., Andermann E., Labuda M., Richter A., Pandolfo M., Cavalcanti F., Pianese L., Iodice L., Farina G., Monticelli A., Turano M., Filla A., De Michele G., and Cocozza S. The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum. Mol. Genet. 6 (1997) 1261-1266
11. Durr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C., Mandel J.L., Brice A., and Koenig M. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335 (1996) 1169-1175
12. Mateo I., Llorca J., Volpini V., Corral J., Berciano J., and Combarros O. GAA expansion size and age at onset of Friedreich's ataxia. Neurology 61 (2003) 274-275
13. Bidichandani S.I., Garcia C.A., Patel P.I., and Dimachkie M.M. Very late-onset Friedreich ataxia despite large GAA triplet repeat expansions. Arch. Neurol. 57 (2000) 246-251
14. Bidichandani S.I., Ashizawa T., and Patel P.I. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am. J. Hum. Genet. 62 (1998) 111-121
15. Campuzano V., Montermini L., Lutz Y., Cova L., Hindelang C., Jiralerspong S., Trottier Y., Kish S.J., Faucheux B., Trouillas P., Authier F.J., Durr A., Mandel J.L., Vescovi A., Pandolfo M., and Koenig M. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum. Mol. Genet. 6 (1997) 1771-1780
16. Ohshima K., Montermini L., Wells R.D., and Pandolfo M. Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J. Biol. Chem. 273 (1998) 14588-14595
17. Pianese L., Turano M., Lo Casale M.S., De Biase I., Giacchetti M., Monticelli A., Criscuolo C., Filla A., and Cocozza S. Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1061-1063
18. Bencze K.Z., Kondapalli K.C., Cook J.D., McMahon S., Millan-Pacheco C., Pastor N., and Stemmler T.L. The structure and function of frataxin. Crit. Rev. Biochem. Mol. Biol. 41 (2006) 269-291
19. Cook J.D., Bencze K.Z., Jankovic A.D., Crater A.K., Busch C.N., Bradley P.B., Stemmler A.J., Spaller M.R., and Stemmler T.L. Monomeric yeast frataxin is an iron-binding protein. Biochemistry 45 (2006) 7767-7777
20. Lu C., and Cortopassi G. Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. Arch. Biochem. Biophys. 457 (2007) 111-122
21. Bulteau A.L., O'Neill H.A., Kennedy M.C., Ikeda-Saito M., Isaya G., and Szweda L.I. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305 (2004) 242-245
22. Gakh O., Park S., Liu G., Macomber L., Imlay J.A., Ferreira G.C., and Isaya G. Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum. Mol. Genet. 15 (2006) 467-479
23. Anderson P.R., Kirby K., Orr W.C., Hilliker A.J., and Phillips J.P. Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia. Proc. Natl. Acad. Sci. USA 105 (2008) 611-616
24. Runko A.P., Griswold A.J., and Min K.T. Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila. FEBS Lett. 582 (2008) 715-719
25. Babady N.E., Carelle N., Wells R.D., Rouault T.A., Hirano M., Lynch D.R., Delatycki M.B., Wilson R.B., Isaya G., and Puccio H. Advancements in the pathophysiology of Friedreich's ataxia and new prospects for treatments. Mol. Genet. Metab. (2007)
26. Grant L., Sun J., Xu H., Subramony S.H., Chaires J.B., and Hebert M.D. Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia. FEBS Lett. 580 (2006) 5399-5405
27. Herman D., Jenssen K., Burnett R., Soragni E., Perlman S.L., and Gottesfeld J.M. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat. Chem. Biol. 2 (2006) 551-558
28. Sarsero J.P., Li L., Wardan H., Sitte K., Williamson R., and Ioannou P.A. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia. J. Gene Med. 5 (2003) 72-81
29. Burnett R., Melander C., Puckett J.W., Son L.S., Wells R.D., Dervan P.B., and Gottesfeld J.M. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia. Proc. Natl. Acad. Sci. USA 103 (2006) 11497-11502
30. Sturm B., Stupphann D., Kaun C., Boesch S., Schranzhofer M., Wojta J., Goldenberg H., and Scheiber-Mojdehkar B. Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur. J. Clin. Invest. 35 (2005) 711-717
31. Cavadini P., O'Neill H.A., Benada O., and Isaya G. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum. Mol. Genet. 11 (2002) 217-227
32. Cavadini P., Adamec J., Taroni F., Gakh O., and Isaya G. Two-step processing of human frataxin by mitochondrial processing peptidase. Precursor and intermediate forms are cleaved at different rates. J. Biol. Chem. 275 (2000) 41469-41475
33. Marusich M.F. Efficient hybridoma production using previously frozen splenocytes. J. Immunol. Methods 114 (1988) 155-159
34. O'Neill H.A., Gakh O., and Isaya G. Supramolecular assemblies of human frataxin are formed via subunit-subunit interactions mediated by a non-conserved amino-terminal region. J. Mol. Biol. 345 (2005) 433-439
35. Koutnikova H., Campuzano V., and Koenig M. Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase. Hum. Mol. Genet. 7 (1998) 1485-1489
36. Yoon T., Dizin E., and Cowan J.A. N-terminal iron-mediated self-cleavage of human fratax: regulation of iron binding and complex formation with target proteins. J. Biol. Inorg. Chem. 12 (2007) 535-542
37. Condo I., Ventura N., Malisan F., Rufini A., Tomassini B., and Testi R. In vivo maturation of human frataxin. Hum. Mol. Genet. 16 (2007) 1534-1540
38. Foury F. Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain. FEBS Lett. 456 (1999) 281-284
39. Rotig A., de Lonlay P., Chretien D., Foury F., Koenig M., Sidi D., Munnich A., and Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet. 17 (1997) 215-217
40. Shan Y., Napoli E., and Cortopassi G. Mitochondrial frataxin interacts with ISD11 of the Nfs1/ISCU complex and multiple mitochondrial chaperones. Hum. Mol. Genet. (2007)
41. Stehling O., Elsasser H.P., Bruckel B., Muhlenhoff U., and Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum. Mol. Genet. 13 (2004) 3007-3015
42. Coppola G., Choi S.H., Santos M.M., Miranda C.J., Tentler D., Wexler E.M., Pandolfo M., and Geschwind D.H. Gene expression profiling in frataxin deficient mice: microarray evidence for significant expression changes without detectable neurodegeneration. Neurobiol. Dis. 22 (2006) 302-311